Triple Negative Breast Cancer Epidemiology Forecast to 2032: Highlights Emerging Trends and Patient Pool Growth in Key Regions
January 30, 2024 06:43 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Triple Negative Breast Cancer - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Industry experts have...
HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
January 24, 2024 10:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
HER2 Inhibitors Global Market Report 2023: Featuring F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Boehringer-Ingelheim, Mylan & Biocon
April 07, 2023 07:03 ET
|
Research and Markets
Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global her2 inhibitors market is expected...
Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021
October 22, 2021 04:53 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...